Italia markets closed

BMY Jan 2025 62.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,3100+0,0100 (+3,33%)
In data: 12:10PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,3000
Aperto0,2900
Denaro0,2900
Lettera0,3200
Prezzo d'esercizio62,50
Scadenza2025-01-17
Min-Max giorno0,2900 - 0,3500
Contratto - Min-MaxN/D
Volume7
Open Interest1,95k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri